had higher alcohol preference that naltrexone reduced providing additional evidence supporting the therapeutic potential of naltrexone. Efforts such as these that work across human and animal studies to examine how genes modify responses to pharmacological agents may ultimately inform our understanding of different pathways to the development of alcohol dependence without finding an association with alcohol dependence per se (Weirs et al., 2009).
